Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients

Abstract Introduction The validated 40-gene expression profile (40-GEP) test independently stratifies risk of regional or distant metastasis for cutaneous squamous cell carcinoma (cSCC) tumors with high-risk clinicopathologic features. This study evaluated the stratification of risk by the 40-GEP te...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ashley Wysong, Ally‐Khan Somani, Sherrif F. Ibrahim, Javier Cañueto, Alison L. Fitzgerald, Jennifer J. Siegel, Anesh Prasai, Matthew S. Goldberg, Aaron S. Farberg, Christie Regula, Anna Bar, Julia Kasprzak, David G. Brodland, Shlomo A. Koyfman, Sarah T. Arron
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Adis, Springer Healthcare 2024-03-01
coleção:	Dermatology and Therapy
Assuntos:	40-GEP Cutaneous squamous cell carcinoma Metastasis Prognostic Risk assessment
Acesso em linha:	https://doi.org/10.1007/s13555-024-01111-5
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!